Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on Interstate 105 Near Long Beach Boulevard


Several Vehicles Collide in Fatal Lynwood Accident 

Lynwood, CA (March 22, 2020) – One person was killed in a multi-vehicle crash in Lynwood. The fatal accident occurred on the evening of March 22 on Interstate 105.

Several vehicles collided in the westbound lanes of Interstate 105, near Long Beach Boulevard. One person was killed in the crash.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Lynwood

#90262


February 28, 2020

Man Killed in Pedestrian Crash on Crenshaw Boulevard

SUV Hits Victim in Fatal Torrance Accident ...


October 23, 2019

3 Killed, 1 Injured in Crash on Highway 88 Near Blue Sky Drive

3 Vehicles Involved in Fatal Ione Accident Ione, CA (October 21, 2019) – Thre...


January 20, 2020

Man Hit by Car After Exiting Vehicle on Interstate 80 Near Antelope CHP Scales

Victim Dies in Fatal Citrus Heights Crash ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.